CN102133245A - 降低蛋白质含量的鸦胆子油及其药物组合物以及它们的制备方法 - Google Patents
降低蛋白质含量的鸦胆子油及其药物组合物以及它们的制备方法 Download PDFInfo
- Publication number
- CN102133245A CN102133245A CN201110062615.3A CN201110062615A CN102133245A CN 102133245 A CN102133245 A CN 102133245A CN 201110062615 A CN201110062615 A CN 201110062615A CN 102133245 A CN102133245 A CN 102133245A
- Authority
- CN
- China
- Prior art keywords
- fructus bruceae
- oleum fructus
- light component
- preparation
- oleum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 49
- 241001533159 Brucea javanica Species 0.000 title claims abstract description 29
- 235000010889 Rhus javanica Nutrition 0.000 title claims abstract description 29
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 28
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 28
- 239000003814 drug Substances 0.000 title abstract description 8
- 239000002131 composite material Substances 0.000 title abstract 2
- 239000000839 emulsion Substances 0.000 claims abstract description 52
- 239000003921 oil Substances 0.000 claims abstract description 39
- 238000000034 method Methods 0.000 claims abstract description 30
- 239000009969 fructus bruceae Substances 0.000 claims description 164
- 238000000199 molecular distillation Methods 0.000 claims description 41
- 239000000203 mixture Substances 0.000 claims description 24
- 235000013399 edible fruits Nutrition 0.000 claims description 23
- 238000000605 extraction Methods 0.000 claims description 23
- 239000007924 injection Substances 0.000 claims description 23
- 238000002347 injection Methods 0.000 claims description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 22
- 238000000108 ultra-filtration Methods 0.000 claims description 21
- 238000004821 distillation Methods 0.000 claims description 19
- 230000001804 emulsifying effect Effects 0.000 claims description 17
- 239000002994 raw material Substances 0.000 claims description 17
- 239000003995 emulsifying agent Substances 0.000 claims description 16
- 239000008215 water for injection Substances 0.000 claims description 16
- 238000004945 emulsification Methods 0.000 claims description 15
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 14
- 239000000243 solution Substances 0.000 claims description 14
- 239000008194 pharmaceutical composition Substances 0.000 claims description 12
- 239000000463 material Substances 0.000 claims description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 10
- 239000004816 latex Substances 0.000 claims description 10
- 229920000126 latex Polymers 0.000 claims description 10
- 239000007788 liquid Substances 0.000 claims description 10
- 238000003756 stirring Methods 0.000 claims description 10
- 239000003795 chemical substances by application Substances 0.000 claims description 9
- 239000000047 product Substances 0.000 claims description 9
- 230000000717 retained effect Effects 0.000 claims description 9
- 239000003381 stabilizer Substances 0.000 claims description 9
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 claims description 7
- 206010020751 Hypersensitivity Diseases 0.000 claims description 7
- 238000001816 cooling Methods 0.000 claims description 7
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 6
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 claims description 6
- 239000012535 impurity Substances 0.000 claims description 6
- 239000007951 isotonicity adjuster Substances 0.000 claims description 6
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 claims description 5
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 claims description 5
- 239000005642 Oleic acid Substances 0.000 claims description 5
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 claims description 5
- 210000003022 colostrum Anatomy 0.000 claims description 5
- 235000021277 colostrum Nutrition 0.000 claims description 5
- 239000000706 filtrate Substances 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 5
- 235000011187 glycerol Nutrition 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 5
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 claims description 5
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims description 5
- 235000021313 oleic acid Nutrition 0.000 claims description 5
- 230000003252 repetitive effect Effects 0.000 claims description 5
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 claims description 4
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 claims description 4
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 4
- BAECOWNUKCLBPZ-HIUWNOOHSA-N Triolein Natural products O([C@H](OCC(=O)CCCCCCC/C=C\CCCCCCCC)COC(=O)CCCCCCC/C=C\CCCCCCCC)C(=O)CCCCCCC/C=C\CCCCCCCC BAECOWNUKCLBPZ-HIUWNOOHSA-N 0.000 claims description 4
- PHYFQTYBJUILEZ-UHFFFAOYSA-N Trioleoylglycerol Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC PHYFQTYBJUILEZ-UHFFFAOYSA-N 0.000 claims description 4
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 claims description 4
- 235000020661 alpha-linolenic acid Nutrition 0.000 claims description 4
- 239000000919 ceramic Substances 0.000 claims description 4
- 239000000787 lecithin Substances 0.000 claims description 4
- 235000010445 lecithin Nutrition 0.000 claims description 4
- 229940067606 lecithin Drugs 0.000 claims description 4
- 229960004488 linolenic acid Drugs 0.000 claims description 4
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 claims description 4
- 239000012466 permeate Substances 0.000 claims description 4
- PHYFQTYBJUILEZ-IUPFWZBJSA-N triolein Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC PHYFQTYBJUILEZ-IUPFWZBJSA-N 0.000 claims description 4
- 235000021355 Stearic acid Nutrition 0.000 claims description 3
- 229940114079 arachidonic acid Drugs 0.000 claims description 3
- 235000021342 arachidonic acid Nutrition 0.000 claims description 3
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 claims description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims description 3
- -1 polyoxyethylene Polymers 0.000 claims description 3
- 239000008117 stearic acid Substances 0.000 claims description 3
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 claims description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 2
- 102000002322 Egg Proteins Human genes 0.000 claims description 2
- 108010000912 Egg Proteins Proteins 0.000 claims description 2
- 241000287828 Gallus gallus Species 0.000 claims description 2
- 229930195725 Mannitol Natural products 0.000 claims description 2
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 claims description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 2
- 239000002202 Polyethylene glycol Substances 0.000 claims description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 2
- 239000004359 castor oil Substances 0.000 claims description 2
- 235000019438 castor oil Nutrition 0.000 claims description 2
- 239000006185 dispersion Substances 0.000 claims description 2
- 150000002168 ethanoic acid esters Chemical class 0.000 claims description 2
- 239000000469 ethanolic extract Substances 0.000 claims description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims description 2
- 239000000594 mannitol Substances 0.000 claims description 2
- 235000010355 mannitol Nutrition 0.000 claims description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 2
- 210000004681 ovum Anatomy 0.000 claims description 2
- 229960000502 poloxamer Drugs 0.000 claims description 2
- 229920001983 poloxamer Polymers 0.000 claims description 2
- 229920001223 polyethylene glycol Polymers 0.000 claims description 2
- 229920000136 polysorbate Polymers 0.000 claims description 2
- 229950008882 polysorbate Drugs 0.000 claims description 2
- 239000000600 sorbitol Substances 0.000 claims description 2
- 235000010356 sorbitol Nutrition 0.000 claims description 2
- 229940083466 soybean lecithin Drugs 0.000 claims description 2
- 239000008347 soybean phospholipid Substances 0.000 claims description 2
- 239000000811 xylitol Substances 0.000 claims description 2
- 235000010447 xylitol Nutrition 0.000 claims description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 2
- 229960002675 xylitol Drugs 0.000 claims description 2
- 239000000890 drug combination Substances 0.000 claims 3
- MLOCEVRFZHPNPT-LATCQUSVSA-N CCCCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCCCCCC(O)=O Chemical compound CCCCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCCCCCC(O)=O MLOCEVRFZHPNPT-LATCQUSVSA-N 0.000 claims 1
- 239000007864 aqueous solution Substances 0.000 claims 1
- 239000010685 fatty oil Substances 0.000 abstract description 7
- 230000000694 effects Effects 0.000 abstract description 5
- 206010002198 Anaphylactic reaction Diseases 0.000 abstract description 3
- 208000003455 anaphylaxis Diseases 0.000 abstract description 3
- 229940079593 drug Drugs 0.000 abstract 1
- 239000002075 main ingredient Substances 0.000 abstract 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 32
- 235000019198 oils Nutrition 0.000 description 30
- 238000012360 testing method Methods 0.000 description 19
- 239000003208 petroleum Substances 0.000 description 18
- 239000000284 extract Substances 0.000 description 10
- 239000012567 medical material Substances 0.000 description 10
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 6
- 230000007774 longterm Effects 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 241000700199 Cavia porcellus Species 0.000 description 4
- 206010070834 Sensitisation Diseases 0.000 description 4
- 239000000427 antigen Substances 0.000 description 4
- 102000036639 antigens Human genes 0.000 description 4
- 108091007433 antigens Proteins 0.000 description 4
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 4
- 238000013467 fragmentation Methods 0.000 description 4
- 238000006062 fragmentation reaction Methods 0.000 description 4
- 230000008313 sensitization Effects 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 238000007689 inspection Methods 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 238000013112 stability test Methods 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 235000021357 Behenic acid Nutrition 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 208000000260 Warts Diseases 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 208000026935 allergic disease Diseases 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- 230000036783 anaphylactic response Effects 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 230000000680 avirulence Effects 0.000 description 2
- 229940116226 behenic acid Drugs 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 229940121657 clinical drug Drugs 0.000 description 2
- 238000009833 condensation Methods 0.000 description 2
- 230000005494 condensation Effects 0.000 description 2
- KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 239000012259 ether extract Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- LQJBNNIYVWPHFW-QXMHVHEDSA-N gadoleic acid Chemical compound CCCCCCCCCC\C=C/CCCCCCCC(O)=O LQJBNNIYVWPHFW-QXMHVHEDSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 201000004792 malaria Diseases 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 238000007670 refining Methods 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 201000010153 skin papilloma Diseases 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 239000001117 sulphuric acid Substances 0.000 description 2
- 235000011149 sulphuric acid Nutrition 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 238000004448 titration Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- BHQCQFFYRZLCQQ-UHFFFAOYSA-N (3alpha,5alpha,7alpha,12alpha)-3,7,12-trihydroxy-cholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 BHQCQFFYRZLCQQ-UHFFFAOYSA-N 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 241000158621 Brucea Species 0.000 description 1
- COXVTLYNGOIATD-HVMBLDELSA-N CC1=C(C=CC(=C1)C1=CC(C)=C(C=C1)\N=N\C1=C(O)C2=C(N)C(=CC(=C2C=C1)S(O)(=O)=O)S(O)(=O)=O)\N=N\C1=CC=C2C(=CC(=C(N)C2=C1O)S(O)(=O)=O)S(O)(=O)=O Chemical compound CC1=C(C=CC(=C1)C1=CC(C)=C(C=C1)\N=N\C1=C(O)C2=C(N)C(=CC(=C2C=C1)S(O)(=O)=O)S(O)(=O)=O)\N=N\C1=CC=C2C(=CC(=C(N)C2=C1O)S(O)(=O)=O)S(O)(=O)=O COXVTLYNGOIATD-HVMBLDELSA-N 0.000 description 1
- 239000004380 Cholic acid Substances 0.000 description 1
- 241001517488 Clavus Species 0.000 description 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- LZKVXMYVBSNXER-YZPKDWIXSA-N Glaucarubin Chemical compound O[C@@H]([C@]1(C)[C@@H]23)[C@@H](O)C=C(C)[C@@H]1C[C@@H]1[C@@]43CO[C@@]2(O)[C@H](O)[C@H](C)[C@@H]4[C@@H](OC(=O)[C@@](C)(O)CC)C(=O)O1 LZKVXMYVBSNXER-YZPKDWIXSA-N 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 238000004061 bleaching Methods 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 210000001715 carotid artery Anatomy 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 235000019416 cholic acid Nutrition 0.000 description 1
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 1
- 229960002471 cholic acid Drugs 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 229960003964 deoxycholic acid Drugs 0.000 description 1
- KXGVEGMKQFWNSR-LLQZFEROSA-N deoxycholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 KXGVEGMKQFWNSR-LLQZFEROSA-N 0.000 description 1
- 230000035617 depilation Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000013583 drug formulation Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 229960003699 evans blue Drugs 0.000 description 1
- 230000003311 flocculating effect Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 230000004345 fruit ripening Effects 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 238000003475 lamination Methods 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 229960002969 oleic acid Drugs 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000012207 quantitative assay Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 238000002390 rotary evaporation Methods 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000008354 sodium chloride injection Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
批号 | 样品1 | 样品2 | 样品3 | 样品4 | 样品5 |
蛋白质含量 | 0.44% | <0.013% | 0.025% | 0.031% | <0.013% |
试验条件 | 实施例6 | 实施例7 | 实施例8 |
鸦胆子油用量(样品3) | 1000ml | 1000ml | 1000ml |
豆磷脂用量 | 150g | 100g | 200g |
甘油用量 | 250g | 200g | 300g |
乳化次数 | 3 | 2 | 6 |
乳化压力 | 40MPa | 80MPa | 20MPa |
Claims (18)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110062615.3A CN102133245B (zh) | 2011-03-16 | 2011-03-16 | 降低蛋白质含量的鸦胆子油及其药物组合物以及它们的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110062615.3A CN102133245B (zh) | 2011-03-16 | 2011-03-16 | 降低蛋白质含量的鸦胆子油及其药物组合物以及它们的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102133245A true CN102133245A (zh) | 2011-07-27 |
CN102133245B CN102133245B (zh) | 2013-01-09 |
Family
ID=44293258
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201110062615.3A Active CN102133245B (zh) | 2011-03-16 | 2011-03-16 | 降低蛋白质含量的鸦胆子油及其药物组合物以及它们的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102133245B (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103740464A (zh) * | 2014-01-01 | 2014-04-23 | 湖北宜恒茶油产业科技有限责任公司 | 一种破乳纯化植物毛油的方法 |
CN104726202A (zh) * | 2013-12-19 | 2015-06-24 | 上海良友(集团)有限公司 | 一种薄膜精馏制取药品级大豆亚油酸的方法 |
CN106309515A (zh) * | 2015-07-08 | 2017-01-11 | 上海中医药大学附属龙华医院 | 鸦胆子油溶致液晶纳米粒分散体、原料组合物及制备方法 |
CN108853160A (zh) * | 2017-05-08 | 2018-11-23 | 沈阳药大雷允上药业有限责任公司 | 鸦胆子油、含鸦胆子油的药物组合物及其制备方法 |
CN112972374A (zh) * | 2019-12-16 | 2021-06-18 | 沈阳药大雷允上药业有限责任公司 | 含鸦胆子油的乳剂的制备方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1488395A (zh) * | 2003-08-28 | 2004-04-14 | 宏 李 | 一种低毒性的鸦胆子油乳注射液及制备方法 |
CN1539481A (zh) * | 2003-10-28 | 2004-10-27 | 卞 力 | 鸦胆子油乳注射液的制备方法 |
CN101129419A (zh) * | 2006-08-22 | 2008-02-27 | 浙江九旭药业有限公司 | 含鸦胆子油的乳化药物组合物及其制备方法 |
CN101683367A (zh) * | 2006-08-22 | 2010-03-31 | 浙江九旭药业有限公司 | 含鸦胆子油的乳化药物组合物的制备方法 |
-
2011
- 2011-03-16 CN CN201110062615.3A patent/CN102133245B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1488395A (zh) * | 2003-08-28 | 2004-04-14 | 宏 李 | 一种低毒性的鸦胆子油乳注射液及制备方法 |
CN1539481A (zh) * | 2003-10-28 | 2004-10-27 | 卞 力 | 鸦胆子油乳注射液的制备方法 |
CN101129419A (zh) * | 2006-08-22 | 2008-02-27 | 浙江九旭药业有限公司 | 含鸦胆子油的乳化药物组合物及其制备方法 |
CN101683367A (zh) * | 2006-08-22 | 2010-03-31 | 浙江九旭药业有限公司 | 含鸦胆子油的乳化药物组合物的制备方法 |
Non-Patent Citations (2)
Title |
---|
《中国实验方剂学杂志》 20060420 林宏英等 鸦胆子油的研究进展 , 第04期 2 * |
《黑龙江医学》 20021010 汪秋红等 鸦胆子油提取制剂及临床应用 , 第10期 2 * |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104726202A (zh) * | 2013-12-19 | 2015-06-24 | 上海良友(集团)有限公司 | 一种薄膜精馏制取药品级大豆亚油酸的方法 |
CN104726202B (zh) * | 2013-12-19 | 2018-01-19 | 上海良友(集团)有限公司 | 一种薄膜精馏制取药品级大豆亚油酸的方法 |
CN103740464A (zh) * | 2014-01-01 | 2014-04-23 | 湖北宜恒茶油产业科技有限责任公司 | 一种破乳纯化植物毛油的方法 |
CN103740464B (zh) * | 2014-01-01 | 2015-11-04 | 湖北宜恒茶油产业科技有限责任公司 | 一种破乳纯化植物毛油的方法 |
CN106309515A (zh) * | 2015-07-08 | 2017-01-11 | 上海中医药大学附属龙华医院 | 鸦胆子油溶致液晶纳米粒分散体、原料组合物及制备方法 |
CN108853160A (zh) * | 2017-05-08 | 2018-11-23 | 沈阳药大雷允上药业有限责任公司 | 鸦胆子油、含鸦胆子油的药物组合物及其制备方法 |
CN112494525A (zh) * | 2017-05-08 | 2021-03-16 | 沈阳药大雷允上药业有限责任公司 | 鸦胆子油、含鸦胆子油的药物组合物及其制备方法 |
CN108853160B (zh) * | 2017-05-08 | 2021-10-22 | 沈阳药大雷允上药业有限责任公司 | 鸦胆子油、含鸦胆子油的药物组合物及其制备方法 |
CN112972374A (zh) * | 2019-12-16 | 2021-06-18 | 沈阳药大雷允上药业有限责任公司 | 含鸦胆子油的乳剂的制备方法 |
CN112972374B (zh) * | 2019-12-16 | 2022-11-04 | 沈阳药大雷允上药业有限责任公司 | 含鸦胆子油的乳剂的制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN102133245B (zh) | 2013-01-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102133245B (zh) | 降低蛋白质含量的鸦胆子油及其药物组合物以及它们的制备方法 | |
AU2017290107A1 (en) | Decarboxylated cannabis resins, uses thereof and methods of making same | |
CN102370761B (zh) | 用于预防或抗过敏的中药复方及其制备方法和应用 | |
CN109363975A (zh) | 一种化妆品用乳香提取物的制备方法与应用 | |
CN102526315A (zh) | 一种荔枝核有效部位群提取物的制备方法 | |
CN109846776A (zh) | 一种积雪草提取液及其制备方法和应用 | |
CN1784251A (zh) | 含类黄酮的组合物的产生方法及其应用 | |
CN109998958A (zh) | 一种川芎美白w/o/w型复乳及其制备方法和应用 | |
CN101804085B (zh) | 鸦胆子油和含鸦胆子油的药物组合物及制备方法 | |
CN1814170A (zh) | 一种治疗心血管疾病的药物滴丸及其制备方法 | |
CN105726363A (zh) | 一种植物护理组合物及其制备方法 | |
CN108853160A (zh) | 鸦胆子油、含鸦胆子油的药物组合物及其制备方法 | |
CN107595714A (zh) | 一种虎杖提取物及其制备方法与在化妆品中的应用 | |
CN112791137B (zh) | 三种五味子提取物及其制备工艺和应用 | |
CN109010429B (zh) | 一种用于祛风止痒的中药制剂及其制备方法与应用 | |
CN110859804B (zh) | 木香提取物微乳剂及其制备方法和用途 | |
CN106491683A (zh) | 一种用于治疗哮喘的款冬花提取物及其制备方法 | |
CN103006633A (zh) | 羟基红花黄色素a在制备抗阿尔茨海默病药物中的应用 | |
WO2016093692A1 (en) | Standardised extract of labisia pumila for weight reduction and nanoformulation thereof | |
CN105250838B (zh) | 一种治疗胼胝的化妆品 | |
CN105943606B (zh) | 一种用于治疗脑缺血的药物组合物及其制备方法 | |
CN109568474B (zh) | 治疗羊口疮的制剂及其制备方法 | |
CN104888113B (zh) | 一种活血化瘀、和络止痛的按摩软膏及其制备方法 | |
CN108918739B (zh) | 一种测定o/w型紫草护肤乳中紫草素的前处理方法及高效液相色谱方法 | |
NL2029794B1 (en) | Application of three yellows and two fragrances powder in the preparation of drugs for preventing and treating uv damage, extract of three yellows and two fragrances powder and cream for preventing and treating uv damage |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: SHENYANG YAODA LEIYYUNSHANG PHARMACEUTICAL CO., LT Free format text: FORMER OWNER: SHENAYANG YAODA PHARMACEUTICAL CO., LTD. Effective date: 20140813 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 110016 SHENYANG, LIAONING PROVINCE TO: 117004 BENXI, LIAONING PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20140813 Address after: Cladrastis 117004 Liaoning Province Economic and Technological Development Zone Benxi Road No. 111 Patentee after: SHENYANG YAODA LEIYUNSHANG PHARMACEUTICAL CO.,LTD. Address before: 110016 No. 103, Wenhua Road, Liaoning, Shenyang Patentee before: SHENYANG YAODA PHARMACEUTICAL Co.,Ltd. |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Brucea javanica oil with reduced protein content, pharmaceutical composition thereof, and preparation method thereof Effective date of registration: 20220921 Granted publication date: 20130109 Pledgee: Bank of China Limited Shenyang Tiexi sub branch Pledgor: SHENYANG YAODA LEIYUNSHANG PHARMACEUTICAL CO.,LTD. Registration number: Y2022210000144 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20230918 Granted publication date: 20130109 Pledgee: Bank of China Limited Shenyang Tiexi sub branch Pledgor: SHENYANG YAODA LEIYUNSHANG PHARMACEUTICAL CO.,LTD. Registration number: Y2022210000144 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |